Keyword: generic drugs

50 results found
Ontario should act cautiously in allowing private label drugs: CLHIA

The Canadian Life and Health Insurance Association is asking the Ontario government to act cautiously in welcoming private label products under the provincial drug program and allowing them to be interchangeable with other products. Presently, the Ontario Drug Benefit Act doesn’t list private label products as drug products, meaning they’re not eligible for public funding under the drug benefit program. […]

  • By: Jann Lee
  • November 30, 2018 September 13, 2019
  • 09:00
How NAFTA negotiations could affect drug prices, pharmacare

The results of the ongoing renegotiations of the North American Free Trade Agreement could have an impact on how much Canadians pay for their medications in the future, according to one expert. In an article originally published by not-for-profit media outlet the Conversation, Joel Lexchin, an associate professor of family and community medicine at the University of Toronto, pointed out that the […]

  • By: Staff
  • September 12, 2018 September 13, 2019
  • 09:00
Pharmacy benefits managers to play growing role in boosting outcomes, addressing costs

Health-care costs are projected to increase a whopping 130 per cent over the next eight years after a period of relatively flat growth, according to a study published by Mercer in 2017. One of the key drivers is rising drug costs, with expensive specialty medications and gene therapies making up the majority of new products in development. So […]

  • April 30, 2018 September 13, 2019
  • 14:22
Lower generic prices not a cure for drug cost pressures

The announcement in late January that 70 of the most commonly prescribed drugs will see their prices fall by as much as 40 per cent on April 1 was certainly welcome news for plan sponsors. The deal, reached by the pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Association, will bring the cost of some generic products down […]

  • March 26, 2018 September 13, 2019
  • 16:14
PMPRB findings on generic drug prices out of date: CGPA

The Canadian Generic Pharmaceutical Association is taking issue with a new report from the Patented Medicine Prices Review Board that raised concerns about high prices for generic drugs in Canada. “The pricing information in the . . . report released today by the PMPRB is from 2016 and does not reflect current prices of generic pharmaceutical products […]

  • By: Staff
  • February 8, 2018 September 13, 2019
  • 10:18
Canada second-highest spender on generic drugs among OECD countries: report

Canadians continue to pay more than most other Organisation for Economic Co-operation and Development countries for generic drugs, despite provincial and territorial policies that have greatly reduced prices in recent years, according to a new report by the Patented Medicine Prices Review Board. The Generics360 report found Canadians spent $165 per capita on generic drugs […]

  • By: Staff
  • February 7, 2018 September 13, 2019
  • 10:46
Empire Life adds new drug-only pooling product

The Empire Life Insurance Co. is introducing a new drug-only pooling product for plan sponsors. With advancement in medicine and higher-cost drugs on the market, it’s important to provide options to help small- and medium-sized businesses manage their high-cost claim exposure, the company noted in a press release. With that in mind, it’s offering the new $7,500 drug-only option […]

  • By: Staff
  • February 2, 2018 September 13, 2019
  • 16:00
Generic drug deal hailed for price cuts of up to 40% for public, private plans

The pan-Canadian Pharmaceutical Alliance and the Canadian Generic Pharmaceutical Association have reached a deal aimed at reducing the prices for some generic drugs by as much as 40 per cent. While the parties are touting significant savings for Canada’s public drug plans, they also say employers and patients will benefit from price reductions of 25 to 40 per cent, as of […]

  • By: Staff
  • January 30, 2018 September 13, 2019
  • 08:30
A look at the five-year forecast for drug plan cost increases

Employers will see private drug plan costs rise by about six per cent annually over the next five years, according to a prediction by a health-care research company. Brad Millson, principal of health access and outcomes at IQVIA, presented the results of his firm’s 2017-21 forecast, produced in partnership with Innovative Medicines Canada, at Benefits […]

Ontario auditor general report takes aim at generic drug prices

The Ontario government may be spending more than it needs to on generic drugs, according to the auditor general’s latest annual report. Auditor general Bonnie Lysyk tabled her 2017 annual report on Wednesday, which found the province doesn’t know whether it’s making any progress in fighting preventable chronic disease. It found total spending by Ontario’s public […]

  • By: Staff
  • December 6, 2017 September 13, 2019
  • 16:00